Participant:
Justin Wright, Co-Founder, Executive Vice President of Data Analytics, Contamination Source Identification (CSI-Dx)
Information:
Here we introduce the cutting-edge CSI-Dx® assay, a RNA-based sequencing technique designed for detecting pathogens in disease states such as Prosthetic Joint Infections (PJIs) and Sepsis. This presentation provides a concise overview of the CSI-Dx® test system and its potential applications. Discover the outcomes of a collaborative study with Zimmer Biomet involving over 320 synovial fluid samples, showcasing the clinical efficacy of CSI-Dx® and its transformative impact on pathogen detection. This collaboration highlights the assay’s role in providing crucial insights into pathogen detection and the downstream potential for better understanding functional gene expression.
Integral to CSI-Dx® is the L7|ESP platform, functioning as a robust Laboratory Information Management System (LIMS) and platform solution. Join us to grasp the essence of CSI-Dx’s® innovation, its clinical significance through a substantial collaborative study, and the streamlined data management offered by the L7|ESP platform.